Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Issue: Product quality
Remove filter for
Recall class: Type II
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 15 of 43 items.
JAMP-Guanfacine XR 4 mg: Foreign matter
RecallHealth product recall | 2024-04-10
JAMP-Rabeprazole 20 mg: Affected lot may contain JAMP-Rabeprazole 10 mg
RecallHealth product recall | 2024-04-02
FOLIC ACID 1MG - Affected lots exceed or may exceed the acceptable intake limit for N-nitroso-folic acid.
RecallHealth product recall | 2024-03-12
JAMP TELMISARTAN-HCT: Affected lots may contain higher dosage than the labelled dose
RecallHealth product recall | 2024-01-24
PEDIATRIX ORAL SOLUTION 100mg: Out of specification
RecallHealth product recall | 2024-01-15
JAMP-ASA EC: out of specification
RecallHealth product recall | 2023-12-04
Votrient: The dissolution is out of specification in the affected lot
RecallHealth product recall | 2023-11-16
PRO-AAS EC 80: out of specification
RecallHealth product recall | 2023-11-08
ELIGARD 7.5mg: may not be filled with correct amount of leuprolide acetate.
RecallHealth product recall | 2023-09-12
Multi-Peptide Lash Serum: undeclared ingredient and sold without market authorization
RecallHealth product recall | 2023-08-21
PMS-Montelukast: An impurity is out of trend
RecallHealth product recall | 2023-08-09
Cromolyn Eye Drops: Out of Specification
RecallHealth product recall | 2023-08-02
JAMP-URSODIOL: Dissolution is out of specification in affected lots
RecallHealth product recall | 2023-07-28
AG-URSODIOL: Dissolution is out of specification in affected lots.
RecallHealth product recall | 2023-07-28
Rhinaris Nasal Mist: Out of specification - Antimicrobial Effectiveness
RecallHealth product recall | 2023-06-30